2m 2m 2m 2m 2m 2m 2m
Liquidia (LQDA)
NASDAQ
$28.59+$0.60 (+2.13%)
Price as of Oct 02, 2026 5:34 PM EDT- $2.5BMarket Cap
- 27.81%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Liquidia (LQDA)
$28.59+$0.60 (+2.13%)
LQDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $27.99 | ||
Change | -$2.27 (-7.50%) | ||
Open | $23.96 | ||
High | $28.10 | ||
Low | $22.31 | ||
Previous Close | $30.26 | ||
Volume | 21,573,271 | ||
30-Day Average Volume | 3,158,292 | ||
1-Week Change | -60.55% | ||
1-Month Change | -58.17% | ||
1-Year Change | 27.81% | ||
3-Year Change | 341.48% | ||
5-Year Change | 917.82% | ||
Fundamentals | |||
Shares Outstanding | 89.5M | ||
Total Assets | $521.9M | ||
Market Cap | $2.5B | ||
Enterprise Value | $2.2B | ||
Period: QTR TTM FY | |||
Revenue | $170.4M | ||
Net Income | $74.7M | ||
Free Cash Flow | $69.0M | ||
EBIT | $81.7M | ||
EBITDA | $82.1M | ||
Net Working Capital | $248.4M | ||
EPS | $0.74 | ||
Enterprise Value/EBITDA | 27 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 13 | ||
P/E | 38 | ||
PEG | 1 | ||
Price/Free Cash Flow | 36 | ||
Price/Operating Cash Flow | 31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue